Literature DB >> 9727525

Cancer-associated retinopathy vs recoverin-associated retinopathy.

J L Keltner, C E Thirkill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9727525     DOI： 10.1016/s0002-9394(98)00212-8

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  9 in total

1.  Update on paraneoplastic neurologic disorders.

Authors:  Myrna R Rosenfeld; Josep Dalmau
Journal:  Oncologist       Date:  2010-05-17

2.  Update on paraneoplastic neurologic disorders.

Authors:  Josep Dalmau; Myrna R Rosenfeld
Journal:  Community Oncol       Date:  2010-05-01

3.  Autoantibodies in melanoma-associated retinopathy target TRPM1 cation channels of retinal ON bipolar cells.

Authors:  Anuradha Dhingra; Marie E Fina; Adam Neinstein; David J Ramsey; Ying Xu; Gerald A Fishman; Kenneth R Alexander; Haohua Qian; Neal S Peachey; Ronald G Gregg; Noga Vardi
Journal:  J Neurosci       Date:  2011-03-16       Impact factor: 6.167

4.  Distant cancer effects on standardised testing of peripheral vision.

Authors:  W W Dawson; B L Jordan; R D Marsh; K Hazariwala; F P Flowers; T Fang
Journal:  Br J Ophthalmol       Date:  2001-03       Impact factor: 4.638

5.  Screening for tumours in paraneoplastic syndromes: report of an EFNS task force.

Authors:  M J Titulaer; R Soffietti; J Dalmau; N E Gilhus; B Giometto; F Graus; W Grisold; J Honnorat; P A E Sillevis Smitt; R Tanasescu; C A Vedeler; R Voltz; J J G M Verschuuren
Journal:  Eur J Neurol       Date:  2010-09-29       Impact factor: 6.089

Review 6.  Neurologic paraneoplastic syndromes.

Authors:  Edward J Dropcho
Journal:  Curr Oncol Rep       Date:  2004-01       Impact factor: 5.075

7.  Successful treatment of cancer-associated retinopathy with alemtuzumab.

Authors:  Ladan Espandar; Susan O'Brien; Charles Thirkill; Linda A Lubecki; Bita Esmaeli
Journal:  J Neurooncol       Date:  2007-01-25       Impact factor: 4.506

8.  Efficacy of rituximab in non-paraneoplastic autoimmune retinopathy.

Authors:  Katherine Boudreault; Sally Justus; Jesse D Sengillo; Kaspar Schuerch; Winston Lee; Thiago Cabral; Stephen H Tsang
Journal:  Orphanet J Rare Dis       Date:  2017-07-15       Impact factor: 4.123

9.  T Helper 1 Cellular Immunity Toward Recoverin Is Enhanced in Patients With Active Autoimmune Retinopathy.

Authors:  Steven K Lundy; Enayat Nikoopour; Athanasios J Karoukis; Ray Ohara; Mohammad I Othman; Rebecca Tagett; K Thiran Jayasundera; John R Heckenlively
Journal:  Front Med (Lausanne)       Date:  2018-09-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.